ALNOV:EPA
Novacyt SA
€ 0.46
arrow_upward
+0.54%(+0.0025) Siku 1
21 Okt, 17:35:18 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALNOV...
Fungua
€ 0.46
Juu
€ 0.46
Chini
€ 0.46
Mtaji wa soko
34.14M
Wastani wa kiasi cha mauzo
elfu 235.63
Kiasi cha mauzo ya hisa
elfu 37.89
Juu kwa wiki 52
€ 1.04
Chini kwa wiki 52
€ 0.29
EPS
-€ 0.37
Hisa za wawekezaji
72.59M
Idadi ya wafanyakazi
228
Fungua
€ 0.46
Juu
€ 0.46
Chini
€ 0.46
Mtaji wa soko
34.14M
Wastani wa kiasi cha mauzo
elfu 235.63
Kiasi cha mauzo ya hisa
elfu 37.89
Juu kwa wiki 52
€ 1.04
Chini kwa wiki 52
€ 0.29
EPS
-€ 0.37
Hisa za wawekezaji
72.59M
Idadi ya wafanyakazi
228
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Investor's Business Daily
·
saa 2 zilizopita
Dow Jones Futures: Meta, Tesla Are Earnings Movers Late After SpaceX, Super Micro Lead Bullish Nasdaq Move
StockStory
·
dakika 50 zilizopita
CVB Financial’s (NASDAQ:CVBF) Q3 2026 sales beat estimates
TradingView
·
dakika 50 zilizopita
Genenta Science Announces Receipt Of Nasdaq Minimum Bid Price Deficiency Notification
Yahoo Finance
·
saa 2 zilizopita
Prediction: 2026 Will Be the S&P 500's 4th Straight Double-Digit Year
Wasifu
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Kuhusu Novacyt SA
Afisa Mkuu Mtendaji (CEO)David Allmond
Wafanyakazi228
Lilianzishwa3 Jul 2006
Makao makuu-
Sekta-
Tovutinovacyt.com